# Prairie Ventures

> Prairie Ventures is a VC fund in Omaha backing Health Care and Biotechnology. See 5 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: VC Fund
- Location: Omaha, United States
- Total investments: 5
- Last investment: May 2019
- Lead investor: 0%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/company/prairie-ventures
- X (Twitter): https://twitter.com/prairieventure
- Website: http://www.prairieventures.net/

Prairie Ventures is a private investment fund and a cooperative of entrepreneurs and investors. We provide industry experience and leadership with a mission of finding, growing and producing untapped business technology resources and concepts.Established in July of 2000, we currently operate a dynamic portfolio of individual companies andinvestment positions. Our 80+ years of aggregate investment, technology and healthcare experience, as well as our successes in the industry, position us to help you have outstanding outcomes.

## Contacts

5 contacts available for Prairie Ventures. Shizune tracks 1 team members at Prairie Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/prairie-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Biotechnology | 2 | 40% |
| Medical Device | 2 | 40% |
| Farming | 1 | 20% |
| Medical | 1 | 20% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Seed | 1 | 20% |
| Series B | 1 | 20% |
| Debt Financing | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kathy Morrow | Director of Finance & Controller | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Paradigm Diagnostics | Paradigm brings cutting-edge diagnostics and biomarker driven clinical trials to benefit cancer patients.Through Next-Gen Sequencing, and other biomarker analysis, Paradigm is able to provide information about the genomic and proteomic landscape of a patient’s cancer, as well as potential therapies based on the specific characterization of thepatient’s tumor; thus, personalizing each patient’s course of treatment. | $15M | Series B | May 21, 2019 | http://www.paradigmdx.com/ |
| Mikroscan | Mikroscan is committed to partnering with the pathology community by providing technology-enabled products and services that increase a pathologist’s reach, remove barriers to workload efficiency, and enable new discoveries.Their solutions are utilized in hospitals, clinics, universities, and research institutions all over the world. From mobileMOHS labs to medical schools, their technology serves a variety of applications in anatomic pathology, veterinary pathology, teaching, and research settings. Deployed on a tablet, laptop, and desktop systems, Mikroscan’s local and cloud-based solutions address some of the most challenging issues associated with pathology today.Mikroscan was founded in 2011 and headquartered in Carlsbad, California. | $1.6M | Series A | Aug 17, 2015 | http://www.mikroscan.com/ |
| Bioz | Bioz delivers the world’s first search engine for life science experimentation. The Bioz platform empowers life scientists in academia and biopharma to quickly find, compare and select the right products for their experiments, ultimately speeding drug discovery and increasing the rate of success in finding cures for diseases. | $1.5M | Seed | Jul 01, 2015 | https://www.bioz.com/ |
| PerceptiMed | PerceptiMed’s groundbreaking VeriFill™ technology reduces the margin of human error in prescription pill dispensing within retail pharmacies, long-term care facilities and hospitals. Its IdentRx™suite of medication verification and dispensing products are fast, accurate and cost-effective -- providing 100% verification of drug, dosage andmanufacturer for every pill, every time. | $5.4M | Series A | Mar 27, 2015 | http://www.perceptimed.com |
| Terra grain fuels | Terra grain fuels builds a partnership with farmers and provide advice on everything from marketing plans to economic forecasts for crops. | $40M | Debt Financing | Oct 25, 2006 | http://www.terragrainfuels.com/ |

5 of 5 investments shown.

## Co-investors
- [New Science Ventures](https://shizune.co/investors/profile/new-science-ventures) — VC Fund, 2 deals together
- [BlueStone Venture Partners](https://shizune.co/investors/profile/bluestone-venture-partners) — VC Fund, 1 deal together
- [Easton Capital](https://shizune.co/investors/profile/easton-capital) — VC Fund, 1 deal together
- [Golden Opportunities Fund](https://shizune.co/investors/profile/golden-opportunities-fund) — VC Fund, 1 deal together
- [Gore Range Capital](https://shizune.co/investors/profile/gorerange-capital) — VC Fund, 1 deal together
- Investment Saskatchewan — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Prairie Ventures invest in?

Prairie Ventures invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Prairie Ventures?

Public channels for Prairie Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Prairie Ventures?

The team at Prairie Ventures includes Kathy Morrow (Director of Finance & Controller). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co